0001209191-19-015891.txt : 20190304 0001209191-19-015891.hdr.sgml : 20190304 20190304181120 ACCESSION NUMBER: 0001209191-19-015891 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FEES JESSICA CENTRAL INDEX KEY: 0001760391 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38459 FILM NUMBER: 19655659 MAIL ADDRESS: STREET 1: C/O SURFACE ONCOLOGY, ICN. STREET 2: 50 HAMPSHIRE STREET 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surface Oncology, Inc. CENTRAL INDEX KEY: 0001718108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-4096 MAIL ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-01 0 0001718108 Surface Oncology, Inc. SURF 0001760391 FEES JESSICA C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 0 1 0 0 See Remarks Stock Option (Right to Buy) 4.27 2019-03-01 4 A 0 14200 0.00 A 2029-03-01 Common Stock 14200 14200 D Stockk Option (Right to Buy) 4.27 2019-03-01 4 A 0 26000 0.00 A 2029-03-01 Common Stock 26000 26000 D The stock option vests and becomes exercisable in 48 equal monthly installments after November 18, 2018. The stock option vests and becomes exercisable in 48 equal monthly installments after February 12, 2019. Title: Principal Accounting Officer, Principal Financial Officer /s/ Jessica Fees 2019-03-04